Evaluating the Blood Group Typing Industry: Growth Trends and Market Segmentation https://www.marketsandmarkets.com/Market-Reports/blood-group-typing-market-72074095.html The blood group typing market is valued at an estimated USD 2.0 billion in 2023 and is projected to reach USD 3.0 billion by 2028 at a CAGR of 8.7% during the forecast period. Market growth is largely driven by the increasing prevalence of chronic diseases and the rising number of surgical procedures necessitating the need for blood donations. The key players in this market are Bio-Rad Laboratories, Inc. (US), QuidelOrtho Corporation (US), Grifols, S.A. (Spain), Thermo Fisher Scientific Inc. (US), Immucor, Inc. (US), Danaher (US), Merck KGaA (Germany), Quotient Limited (Switzerland), Novacyt (France), BAG Health Care GmbH (Germany), Rapid Labs Ltd (UK), Agena Bioscience, Inc. (US), Biorex Diagnostics (UK), HUMAN Gesellschaft für Biochemica und Diagnostica mbH (Germany), Prestige Diagnostics (UK), Span Diagnostics SARL (France), DIALAB GmbH (Austria), Lorne Laboratories Limited (UK), Atlas Medical GmbH (Germany), Torax Biosciences Limited (Northern Ireland), Fortress Diagnostics (UK), AXO Science (France), Maxwin Health Care Pvt. Ltd. (India), Anamol Laboratories Pvt. Ltd. (India), J. Mitra & Co. Pvt. Ltd. (India), and MedSource Ozone Biomedicals Pvt. Ltd. (India).